Artificial intelligence (AI) continues to be the hottest investing topic on Wall Street, and arguably no stock has performed ...

About This EventH.C. Wainwright & Co., full‐service investment bank, visits the Nasdaq MarketSite in Times Square.In honor of the occasion, the 3rd Annual BioConnect Conference, John Chambers and ...

Now, Ives says the bull case is "back on the table" for tech stocks such as Apple (NASDAQ: AAPL), Microsoft, and Palantir ...

To turn $10,000 into $1 million, Palantir will need to increase in value 100-fold. Today, the company is worth about $300 ...

Among notable players fueling the quantum computing landscape is IonQ (NYSE: IONQ), which has witnessed a 275% rise in its ...

Mercedes-Benz stock (OTCMKTS: MBGAF) has had a relatively strong year so far, rising by close to 7%, outperforming the S&P 500, which has remained roughly flat year-to-date. Things have actually been ...

Mirum Pharmaceuticals, Inc. today announced the appointment of Doug Sheehy, JD, as chief legal officer. Mr. Sheehy was most recently chief legal officer and secretary at Sonoma Biotherapeutics, Inc., ...

Yet another risk is the antitrust trial Meta faces this year, which may result in it having to sell Instagram and/or WhatsApp ...

About This EventLigand (Nasdaq: LGND), a biopharmaceutical royalty aggregator focused on investing in highly differentiated development-stage and commercial products, visits the Nasdaq MarketSite in ...

With so much going right for Palantir, there's only one thing eroding the stock's investment thesis: its extremely expensive valuation. It trades at a forward P/E ratio of 175 and a price-to-free-cash ...

Retail liquidity is growing and becoming a more substantial contributor to U.S. markets. OECD data suggests direct holdings of stocks by U.S. investors are among the highest levels in the world, ...

The stock price reaction was mostly because the market's expectations had risen quite high, and shares of Palantir ended up ...